Detecting colorectal cancer in stool with the use of multiple genetic targets.

BACKGROUND Colorectal cancer cells are shed into the stool, providing a potential means for the early detection of the disease using noninvasive approaches. Our goal was to develop reliable, specific molecular genetic tests for the detection of colorectal cancer in stool samples. METHODS Stool DNA was isolated from paired stools and primary tumor samples from 51 colorectal cancer patients. Three genetic targets-TP53, BAT26, and K-RAS-were used to detect tumor-associated mutations in the stool prior to or without regard to the molecular analyses of the paired tumors. TP53 gene mutations were detected with a mismatch-ligation assay that detects nine common p53 gene mutations. Deletions within the BAT26 locus were detected by a modified solid-phase minisequencing method. Mutations in codons 12 and 13 of K-RAS were detected with a digital polymerase chain reaction-based method. RESULTS TP53 gene mutations were detected in the tumor DNA of 30 patients, all of whom had the identical TP53 mutation in their stools. Tumors from three patients contained a noninherited deletion at the BAT26 locus, and the same alterations were identified in these patients' stool specimens. Nineteen of 50 tumors tested had a K-RAS mutation; identical mutations were detected in the paired stool DNA samples from eight patients. In no case was a mutation found in stool that was not also present in the primary tumor. Thus, the three genetic markers together detected 36 (71%) of 51 patients (95% confidence interval [CI] = 56% to 83%) with colorectal cancer and 36 (92%) of 39 patients (95% CI = 79% to 98%) whose tumors had an alteration. CONCLUSION We were able to detect the majority of colorectal cancers by analyzing stool DNA for just three genetic markers. Additional work is needed to determine the specificity of these genetic tests for detecting colorectal neoplasia in asymptomatic patients and to more precisely estimate the prevalence of the mutations and sensitivity of the assay.

[1]  S. Thibodeau,et al.  Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. , 2000, Gastroenterology.

[2]  S. Winawer,et al.  Screening and surveillance for colorectal cancer. , 2000, Seminars in oncology.

[3]  Francis Barany,et al.  Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2 , 2000, Nature Biotechnology.

[4]  Z. Ronai,et al.  K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review. , 2000, Cancer detection and prevention.

[5]  A. de la Chapelle,et al.  Genetic susceptibility to non-polyposis colorectal cancer , 1999, Journal of medical genetics.

[6]  K. Kinzler,et al.  Digital PCR. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C. Adebamowo,et al.  Polymorphic variation at the BAT-25 and BAT-26 loci in individuals of African origin. Implications for microsatellite instability testing. , 1999, The American journal of pathology.

[8]  M. Leppert,et al.  BAT-26 and BAT-40 instability in colorectal adenomas and carcinomas and germline polymorphisms. , 1999, The American journal of pathology.

[9]  F. Barany,et al.  Biochemical properties of a high fidelity DNA ligase from Thermus species AK16D. , 1999, Nucleic acids research.

[10]  Francis Barany,et al.  Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors , 1999, Oncogene.

[11]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[12]  B. Levin,et al.  Screening and surveillance for colorectal cancer. , 1998, The American journal of managed care.

[13]  R. Deuter,et al.  Detection of APC mutations in stool DNA of patients with colorectal cancer by HD‐PCR , 1998, Human mutation.

[14]  T. Byers,et al.  American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: Update 1997 , 1997 .

[15]  T. Byers,et al.  American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. , 1997, CA: a cancer journal for clinicians.

[16]  M. Perucho.  Cancer of the microsatellite mutator phenotype. , 1996, Biological chemistry.

[17]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[18]  C. Wagener,et al.  Detection of K‐ras mutations in stools of patients with colorectal cancer by mutant‐enriched PCR , 1996, International journal of cancer.

[19]  T. Kanematsu,et al.  Mutations of the p53 gene in the stool of patients with resectable colorectal cancer , 1996, Cancer.

[20]  F. Barany,et al.  Improving the fidelity of Thermus thermophilus DNA ligase. , 1996, Nucleic acids research.

[21]  Thierry Soussi,et al.  P53 Gene Mutation: Software and Database , 1996, Nucleic Acids Res..

[22]  Thierry Soussi,et al.  APC gene: database of germline and somatic mutations in human tumors and cell lines , 1996, Nucleic Acids Res..

[23]  K. Kinzler,et al.  Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. , 1995, Cancer research.

[24]  W. Bodmer,et al.  Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients. , 1995, Gut.

[25]  K. Kinzler,et al.  Molecular determinants of dysplasia in colorectal lesions. , 1994, Cancer research.

[26]  Z. F. Liu,et al.  Allelic loss of chromosome 18q and prognosis in colorectal cancer. , 1994, The New England journal of medicine.

[27]  G. Capellá,et al.  Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas. , 1993, Journal of the National Cancer Institute.

[28]  L M Schuman,et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.

[29]  K. Kinzler,et al.  The multistep nature of cancer. , 1993, Trends in genetics : TIG.

[30]  K. Kinzler,et al.  Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. , 1992, Science.

[31]  K Kontula,et al.  A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. , 1990, Genomics.